- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07616804
Cognitive Responses to Acute Breath-Hold Diving Training in Female Divers
May 27, 2026 updated by: Görkem Açar, Istanbul Gelisim University
Investigation of Cognitive Responses to Acute Breath-Hold Diving Training in Female Divers
This study aims to investigate the acute cognitive and physiological responses to breath-hold diving training in trained female divers.
Participants will complete three separate sessions including a control session, a land-based breath-hold training session, and a water-based breath-hold training session in randomized order.
Cognitive performance, mood state, heart rate responses, respiratory function, and maximal breath-hold capacity will be evaluated before and after the interventions.
The study is expected to improve understanding of how acute apnea-based diving exercises influence cognitive functions and physiological adaptations under different environmental conditions.
Study Overview
Status
Not yet recruiting
Conditions
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Görkem Açar, Ress. Asst.
- Phone Number: +90 545 407 01 98
- Email: gacar@gelisim.edu.tr
Study Locations
-
-
-
Istanbul, Turkey (Türkiye), 34000
- Istanbul Gelisim University
-
Contact:
- Görkem Açar, Ress. Asst.
- Phone Number: +90 545 407 01 98
- Email: gacar@gelisim.edu.tr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Licensed breath-hold or free-diving athletes
- Aged between 18 and 30 years
- Minimum of 5 years of training experience
- No known cardiovascular or pulmonary disease
- Non-smokers
- Willing to participate voluntarily
- Refraining from intense exercise within 24 hours before testing
Exclusion Criteria:
- Use of performance-enhancing drugs or ergogenic aids
- Presence of chronic sports injury
- Alcohol consumption within 24 hours before testing
- Caffeine intake within 2 hours before testing
- Sleep deprivation or severe fatigue
- Current medication use Fear of water or inability to complete breath-hold procedures
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Control Session
Participants will complete baseline cognitive, respiratory, mood, and maximal breath-hold assessments without structured breath-hold exercise.
|
Participants will undergo baseline cognitive, respiratory, mood, and physiological assessments without structured apnea or breath-hold exercise intervention.
|
|
Experimental: Land-Based Breath-Hold Training
Participants will perform land-based breath-hold exercises at 60% of individual maximal breath-hold capacity followed by post-intervention cognitive and mood assessments.
|
Participants will perform structured land-based breath-hold exercises consisting of repeated apnea efforts at 60% of individual maximal breath-hold capacity with standardized rest intervals.
|
|
Experimental: Water-Based Breath-Hold Training
Participants will perform water-based breath-hold exercises in a swimming pool at 60% of individual maximal breath-hold capacity followed by post-intervention cognitive and mood assessments.
|
Participants will perform structured breath-hold exercises in a swimming pool environment consisting of repeated apnea efforts at 60% of individual maximal breath-hold capacity with standardized rest intervals.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Working Memory Accuracy (2-Back Test)
Time Frame: Baseline and immediately after the intervention, within 5 minutes post-intervention.
|
Accuracy score obtained from the computerized 2-back cognitive task.
|
Baseline and immediately after the intervention, within 5 minutes post-intervention.
|
|
Reaction Time During the 2-Back Test
Time Frame: Baseline and immediately after the intervention, within 5 minutes post-intervention.
|
Mean reaction time recorded during correct responses in the 2-back cognitive task.
|
Baseline and immediately after the intervention, within 5 minutes post-intervention.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Brunel Mood Scale (BRUMS) Total Score
Time Frame: Baseline and immediately after the intervention, within 5 minutes post-intervention.
|
Total mood disturbance score assessed using the Brunel Mood Scale questionnaire.
|
Baseline and immediately after the intervention, within 5 minutes post-intervention.
|
|
Maximum Breath-Hold Duration
Time Frame: Baseline during the control session before intervention sessions.
|
Maximum voluntary breath-hold duration recorded during testing.
|
Baseline during the control session before intervention sessions.
|
|
Resting Heart Rate
Time Frame: Before each experimental session.
|
Resting heart rate measured before each session using a Polar heart rate monitor.
|
Before each experimental session.
|
|
Exercise Heart Rate Response
Time Frame: During the intervention session.
|
Heart rate responses recorded every 30 seconds during the breath-hold exercise protocol.
|
During the intervention session.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
August 30, 2026
Study Completion (Estimated)
September 15, 2026
Study Registration Dates
First Submitted
May 7, 2026
First Submitted That Met QC Criteria
May 27, 2026
First Posted (Actual)
June 1, 2026
Study Record Updates
Last Update Posted (Actual)
June 1, 2026
Last Update Submitted That Met QC Criteria
May 27, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- 2026/148
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Performance
-
Texas Tech University Health Sciences CenterTexas Tech UniversityNot yet recruitingStress | Performance | Cognitive Performance | Cognitive AbilitiesUnited States
-
Ankara UniversityBurdur Mehmet Akif Ersoy UniversityCompletedAnaerobic Performance Neuromuscular Performance Cognitive PerformanceTurkey (Türkiye)
-
Atılım UniversityNot yet recruitingCognitive Performance | Physical PerformanceTurkey
-
Krzysztof MizeraCompletedCognitive Performance | Physical PerformancePoland
-
University of MoliseGiuseppe Calcagno; Giovanni Fiorilli; Andrea Buonsenso; Alessandra di CagnoCompletedAcademic Acheivement | Cognitive Performance | Physical PerformanceItaly
-
Inonu UniversityPrincess Nourah bint Abdulrahman University, Riyadh, Saudi ArabiaCompletedHealthy Volunteers | Cognitive Performance | Anaerobic PerformanceTurkey (Türkiye)
-
PepsiCo Global R&DCompletedSleep | Cognitive Performance | Balance | Physical PerformanceAustralia
-
Qassim UniversityCairo UniversityEnrolling by invitationCognitive Performance | Cognitive Performance During Physical Activity | Sustained AttentionSaudi Arabia
-
Sinop UniversityCompletedAthletic Performance | Cognitive Performance | Healthy Adult FemalesTurkey (Türkiye)
-
University of Central LancashireKhyber Medical UniversityCompletedCognitive PerformanceUnited Kingdom
Clinical Trials on Control Session
-
Castilla-La Mancha Health ServiceRecruitingObesity | Diabetes Mellitus, Type 2Spain
-
Centre Hospitalier Universitaire DijonUnknown
-
KU LeuvenUnknownIntermittent Claudication | Peripheral Artery Disease
-
Universidad Rey Juan CarlosParticipating Nursing Homes in Madrid and Asturias, SpainCompletedAging | Empathy SkillsSpain
-
University of CalgaryNot yet recruitingStroke/Brain AttackCanada
-
Groupe Hospitalier du HavreCompletedChronic Obstructive Pulmonary DiseaseFrance
-
Clinique Romande de ReadaptationCompletedStroke | Multiple Sclerosis | Cerebral Palsy | Parkinson Disease | Spinal Cord Injuries | People With Impaired Lower Extremity FunctionSwitzerland
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Royal Holloway UniversitySuspendedDepression | Anxiety Disorders | Anxiety | Low MoodUnited Kingdom
-
University of New MexicoActive, not recruitingType 2 Diabetes Mellitus | PreDiabetesUnited States